
Sheela C. Chawan
Examiner (ID: 5676, Phone: (571)272-7446 , Office: P/2669 )
| Most Active Art Unit | 2669 |
| Art Unit(s) | 2669, 2625, 2621, 2721, 2624, 2623 |
| Total Applications | 1677 |
| Issued Applications | 1463 |
| Pending Applications | 83 |
| Abandoned Applications | 161 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17704971
[patent_doc_number] => 20220204977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => Gold Optimized CAR T-cells
[patent_app_type] => utility
[patent_app_number] => 17/693802
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693802 | Gold optimized CAR T-cells | Mar 13, 2022 | Issued |
Array
(
[id] => 18085726
[patent_doc_number] => 11535846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation
[patent_app_type] => utility
[patent_app_number] => 17/694310
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 32
[patent_no_of_words] => 27072
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/694310 | Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation | Mar 13, 2022 | Issued |
Array
(
[id] => 18172865
[patent_doc_number] => 11572566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Gold optimized CAR t-cells
[patent_app_type] => utility
[patent_app_number] => 17/683075
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 38879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683075
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683075 | Gold optimized CAR t-cells | Feb 27, 2022 | Issued |
Array
(
[id] => 17774969
[patent_doc_number] => 20220241318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
[patent_app_type] => utility
[patent_app_number] => 17/671455
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 98253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/671455 | Altering microbial populations and modifying microbiota | Feb 13, 2022 | Issued |
Array
(
[id] => 17604269
[patent_doc_number] => 11332742
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-17
[patent_title] => Mad nucleases
[patent_app_type] => utility
[patent_app_number] => 17/567800
[patent_app_country] => US
[patent_app_date] => 2022-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8794
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17567800
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/567800 | Mad nucleases | Jan 2, 2022 | Issued |
Array
(
[id] => 17258897
[patent_doc_number] => 20210371882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => METHOD FOR COUNTERSELECTION IN MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/397540
[patent_app_country] => US
[patent_app_date] => 2021-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17397540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/397540 | Method for counterselection in microorganisms | Aug 8, 2021 | Issued |
Array
(
[id] => 17336027
[patent_doc_number] => 20220002358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ARC-BASED CAPSIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/382102
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/382102 | Endogenous Gag-based capsids and uses thereof | Jul 20, 2021 | Issued |
Array
(
[id] => 17604271
[patent_doc_number] => 11332744
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-17
[patent_title] => Safe harbor loci
[patent_app_type] => utility
[patent_app_number] => 17/239484
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 60
[patent_no_of_words] => 28313
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17239484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/239484 | Safe harbor loci | Apr 22, 2021 | Issued |
Array
(
[id] => 17845122
[patent_doc_number] => 11434478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-06
[patent_title] => Compositions and methods for genome engineering with Cas12a proteins
[patent_app_type] => utility
[patent_app_number] => 17/171302
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 40
[patent_no_of_words] => 31584
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171302 | Compositions and methods for genome engineering with Cas12a proteins | Feb 8, 2021 | Issued |
Array
(
[id] => 16868605
[patent_doc_number] => 20210162072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => MODIFIED ADENO-ASSOCIATED VIRUS VECTORS AND DELIVERY THEREOF INTO THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/163244
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17163244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/163244 | Modified adeno-associated virus vectors and delivery thereof into the central nervous system | Jan 28, 2021 | Issued |
Array
(
[id] => 16868608
[patent_doc_number] => 20210162075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => GENE THERAPY CONSTRUCTS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/127001
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/127001 | Gene therapy constructs and methods of use | Dec 17, 2020 | Issued |
Array
(
[id] => 16598411
[patent_doc_number] => 20210024942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => AUREOBASIDIUM PULLULANS STRAINS WITH HIGH-YIELD HEAVY OIL AND CONSTRUCTION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/070948
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070948
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070948 | Aureobasidium pullulans strains with high-yield heavy oil and construction method and application thereof | Oct 14, 2020 | Issued |
Array
(
[id] => 16570968
[patent_doc_number] => 20210009974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => PROGRAMMABLE NUCLEASE IMPROVEMENTS AND COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION AND DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/037620
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17037620
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/037620 | Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection | Sep 28, 2020 | Issued |
Array
(
[id] => 17075121
[patent_doc_number] => 11111507
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Method for counterselection in microorganisms
[patent_app_type] => utility
[patent_app_number] => 17/029200
[patent_app_country] => US
[patent_app_date] => 2020-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 15009
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17029200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/029200 | Method for counterselection in microorganisms | Sep 22, 2020 | Issued |
Array
(
[id] => 16492633
[patent_doc_number] => 10858660
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Gold optimized CAR T-cells
[patent_app_type] => utility
[patent_app_number] => 16/940213
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 38991
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16940213
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/940213 | Gold optimized CAR T-cells | Jul 26, 2020 | Issued |
Array
(
[id] => 16909143
[patent_doc_number] => 11041172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Homology dependent repair genome editing
[patent_app_type] => utility
[patent_app_number] => 16/911156
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 55929
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16911156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/911156 | Homology dependent repair genome editing | Jun 23, 2020 | Issued |
Array
(
[id] => 16506440
[patent_doc_number] => 20200385696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT CONE-ROD DYSTROPHY
[patent_app_type] => utility
[patent_app_number] => 16/899717
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899717
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899717 | Materials and methods for treatment of autosomal dominant cone-rod dystrophy | Jun 11, 2020 | Issued |
Array
(
[id] => 16222760
[patent_doc_number] => 20200247876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => RECOMBINANT COLLAGEN AND ELASTIN MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/839047
[patent_app_country] => US
[patent_app_date] => 2020-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839047 | Recombinant collagen and elastin molecules and uses thereof | Apr 1, 2020 | Issued |
Array
(
[id] => 16157181
[patent_doc_number] => 20200216823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => VECTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/775918
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775918
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775918 | VECTORS AND METHODS OF USE | Jan 28, 2020 | Abandoned |
Array
(
[id] => 15832477
[patent_doc_number] => 20200131520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => Gold Optimized CAR T-cells
[patent_app_type] => utility
[patent_app_number] => 16/739766
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739766
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739766 | Gold optimized CAR T-cells | Jan 9, 2020 | Issued |